- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic BRAF Alterations and Their Role in Brain Tumors
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 6, Pages 794
Publisher
MDPI AG
Online
2019-06-10
DOI
10.3390/cancers11060794
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Molecular Pathways in Intracranial Metastatic Disease
- (2019) Vyshak Alva Venur et al. Frontiers in Oncology
- Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature
- (2019) Bartosz Wojtas et al. Cancers
- Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis
- (2019) Norman L. Lehman et al. Acta Neuropathologica Communications
- Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
- (2019) Ulrich Herrlinger et al. LANCET
- Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors
- (2019) Nozomi Matsumura et al. JOURNAL OF NEURO-ONCOLOGY
- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
- (2018) David Capper et al. ACTA NEUROPATHOLOGICA
- Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
- (2018) Maximilian Y. Deng et al. ACTA NEUROPATHOLOGICA
- Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
- (2018) Garry Ceccon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report
- (2018) Benjamin T. Himes et al. JOURNAL OF NEUROSURGERY
- Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database
- (2018) Jonathan Frandsen et al. JOURNAL OF NEUROSURGERY
- Concurrent BRAF/MEK Inhibitors in BRAF V600–Mutant High-Grade Primary Brain Tumors
- (2018) Karisa C. Schreck et al. Journal of the National Comprehensive Cancer Network
- Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF -Mutated High-Grade Glioma
- (2018) Tanner M. Johanns et al. Journal of the National Comprehensive Cancer Network
- Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) are Distinct Entities with Frequent BRAFV600 Mutations
- (2018) Anthony C Wang et al. MOLECULAR CANCER RESEARCH
- Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma
- (2018) Takuya Furuta et al. NEUROPATHOLOGY
- Review: Molecular characteristics of long-term epilepsy-associated tumours (LEATs) and mechanisms for tumour-related epilepsy (TRE)
- (2018) T. J. Stone et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
- (2018) Asher M. Marks et al. PEDIATRIC BLOOD & CANCER
- The genetic landscape of ganglioglioma
- (2018) Melike Pekmezci et al. Acta Neuropathologica Communications
- Trametinib for progressive pediatric low-grade gliomas
- (2018) Maria Kondyli et al. JOURNAL OF NEURO-ONCOLOGY
- BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors
- (2018) Hyun Yong Koh et al. NATURE MEDICINE
- Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma
- (2018) Mehdi Touat et al. NEUROLOGY
- BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials
- (2018) Taku Fujimura et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Review: Challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype‐phenotype analysis
- (2018) I. Blümcke et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production
- (2018) Ran Chen et al. NEOPLASIA
- Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy
- (2018) Melissa M. Blessing et al. Acta Neuropathologica Communications
- BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas
- (2017) Xin Chen et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
- (2017) Alvaro Lassaletta et al. JOURNAL OF CLINICAL ONCOLOGY
- Gliosarcomas with theBRAFV600E mutation: a report of two cases and review of the literature
- (2017) Leiming Wang et al. JOURNAL OF CLINICAL PATHOLOGY
- Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response
- (2017) Catherine Miller et al. Journal of Neurosurgery-Pediatrics
- A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer
- (2017) David R. Gandara et al. Journal of Thoracic Oncology
- RARE-35. DABRAFENIB IN PATIENTS WITH RECURRENT, BRAF V600E MUTATED MALIGNANT GLIOMA AND LEPTOMENINGEAL DISEASE
- (2017) Michael Burger et al. NEURO-ONCOLOGY
- A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
- (2017) Yu Sun et al. NEURO-ONCOLOGY
- A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
- (2017) Anuradha Banerjee et al. NEURO-ONCOLOGY
- Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib
- (2017) Cornelis M. van Tilburg et al. PEDIATRIC BLOOD & CANCER
- A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
- (2017) Tajana Tešan Tomić et al. PLoS One
- Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation
- (2016) Joanna J. Phillips et al. ACTA NEUROPATHOLOGICA
- Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
- (2016) Barbara Rivera et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Vemurafenib in Metastatic Melanoma Patients with Brain Metastases: An Open-Label, Single-Arm, Phase 2, Multicentre Study
- (2016) GA McArthur et al. ANNALS OF ONCOLOGY
- Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
- (2016) Felix Behling et al. Diagnostic Pathology
- Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs)
- (2016) Aanchal Kakkar et al. EPILEPSY RESEARCH
- Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation
- (2016) Andrew J. Dodgshun et al. JOURNAL OF NEURO-ONCOLOGY
- Morphological and molecular features of astroblastoma, includingBRAFV600Emutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults
- (2016) Norman L. Lehman et al. NEURO-ONCOLOGY
- Gliosarcomas lackBRAFV600Emutation, but a subset exhibit β-catenin nuclear localization
- (2016) Katherine E. Schwetye et al. NEUROPATHOLOGY
- Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations
- (2016) Alenka Gugger et al. PLoS One
- Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
- (2016) Florian Selt et al. Oncotarget
- Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
- (2016) Stefan Grossauer et al. Oncotarget
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Pilocytic astrocytoma: pathology, molecular mechanisms and markers
- (2015) V. Peter Collins et al. ACTA NEUROPATHOLOGICA
- High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN)
- (2015) Fausto J. Rodriguez et al. ACTA NEUROPATHOLOGICA
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation
- (2015) Bette K. Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
- (2015) Sanda Alexandrescu et al. BRAIN PATHOLOGY
- Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA
- (2015) Bette K. Kleinschmidt-DeMasters et al. BRAIN PATHOLOGY
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
- (2015) Zhan Yao et al. CANCER CELL
- Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification
- (2015) Midea Gierke et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma
- (2015) Tina Dasgupta et al. JOURNAL OF NEURO-ONCOLOGY
- BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum
- (2015) Claire Faulkner et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Diagnostic, prognostic and predictive relevance of molecular markers in gliomas
- (2015) Sebastian Brandner et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib
- (2015) Dolly Aguilera et al. PEDIATRIC BLOOD & CANCER
- Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways
- (2015) Tania A. Jones et al. Acta Neuropathologica Communications
- Constitutive Activation of Raf-1 Induces Glioma Formation in Mice
- (2015) Yelena Lyustikman et al. NEOPLASIA
- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- Chromosome Band 7q34 Deletions Resulting inKIAA1549-BRAFandFAM131B-BRAFFusions in Pediatric Low-Grade Gliomas
- (2014) Jacquelyn J. Roth et al. BRAIN PATHOLOGY
- Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up
- (2014) Cristiane M. Ida et al. BRAIN PATHOLOGY
- Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation
- (2014) Shingo Tanaka et al. Brain Tumor Pathology
- New IDH1 I113T mutation associated with BRAF V600E mutation: New driver of gliomagenesis?
- (2014) E. Tabouret et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
- (2014) Francesca del Bufalo et al. Journal of Translational Medicine
- Oncogenic BRAF inhibitor UAI-201 induces cell cycle arrest and autophagy in BRAF mutant glioma cells
- (2014) Jun-Ho Ahn et al. LIFE SCIENCES
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
- (2014) Priscilla K Brastianos et al. NATURE GENETICS
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
- (2014) M. A. Karajannis et al. NEURO-ONCOLOGY
- Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
- (2014) J. M. M. Levy et al. Cancer Discovery
- Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups
- (2014) Kirti Gupta et al. Acta Neuropathologica Communications
- Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
- (2013) Sonika Dahiya et al. ACTA NEUROPATHOLOGICA
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- (2013) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600EMutation and Expression
- (2013) Céline Chappé et al. BRAIN PATHOLOGY
- Pediatric Brainstem Gangliogliomas ShowBRAFV600EMutation in a High Percentage of Cases
- (2013) Andrew M. Donson et al. BRAIN PATHOLOGY
- BRAF V600E Mutation Is Associated with mTOR Signaling Activation in Glioneuronal Tumors
- (2013) Avanita S. Prabowo et al. BRAIN PATHOLOGY
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide DNA Copy Number Analysis of Desmoplastic Infantile Astrocytomas and Desmoplastic Infantile Gangliogliomas
- (2013) Marco Gessi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
- (2013) A. J. Sievert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent BRAF Gain in Low-Grade Diffuse Gliomas with 1p/19q Loss
- (2012) Young-Ho Kim et al. BRAIN PATHOLOGY
- BRAF Alterations Are Frequent in Cerebellar Low-Grade Astrocytomas With Diffuse Growth Pattern
- (2012) Cristiane M. Ida et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
- (2012) E. Q. Lee et al. NEURO-ONCOLOGY
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas
- (2011) K. Jacob et al. CLINICAL CANCER RESEARCH
- BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model
- (2011) E. H. Raabe et al. CLINICAL CANCER RESEARCH
- BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults
- (2011) M. Hasselblatt et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
- (2011) Dora Dias-Santagata et al. PLoS One
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
- (2009) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
- (2009) Tim Forshew et al. JOURNAL OF PATHOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
- (2009) D T W Jones et al. ONCOGENE
- Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation
- (2009) J P Robinson et al. ONCOGENE
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started